Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines
Protext Mobility, Inc.
258 South Military Trail
Deerfield Beach, FL. 33442
617-504-3635
SIC 2833
QuarterlyReport
For the Period Ending: September 30, 2021
(the "Reporting Period")
As of September 30,, 2021, the number of shares outstanding of our Common Stock was:
7,388,175,006
As of June 30, 2021, the number of shares outstanding of our Common Stock was:
6,935,545,780
As of December 31, 2020, the number of shares outstanding of our Common Stock was:
4,874,316,008
Indicate by check mark whether the company is a shell company (as defined in Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Exchange Act of 1934):
Yes: ☐ | No: ☒ |
Indicate by check mark whether the company's shell status has changed since the previous reporting period:
Yes: ☐ | No: ☒ |
Indicate by check mark whether a Change in Control1 of the company has occurred over this reporting period:
Yes: ☐ | No: ☒ |
- Name and address(es) of the issuer and its predecessors (if any)
In answering this item, provide the current name of the issuer any names used by predecessor entities, along with the dates of the name changes.
Protext Mobility- December 2010 - present
EchoMetrix- May, 2009- December, 2010
SearchHelp, Inc.- September, 2001 -May, 2009
1 "Change in Control" shall mean any events resulting in:
- Any "person" (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the "beneficial owner" (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company's then outstanding voting securities;
- The consummation of the sale or disposition by the Company of all or substantially all of the Company's assets;
- A change in the composition of the Board occurring within a two (2)-year period, as a result of which fewer than a majority of the directors are directors immediately prior to such change; or
- The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.
2
The state of incorporation or registration of the issuer and of each of its predecessors (if any) during the past five years; Please also include the issuer's current standing in its state of incorporation (e.g. active, default, inactive):
Name | State of incorporation | Standing |
Protext Mobility | Delaware | Active |
Describe any trading suspension orders issued by the SEC concerning the issuer or its predecessors since inception:
None
List any stock split, stock dividend, recapitalization, merger, acquisition, spin-off, or reorganization either currently anticipated or that occurred within the past 12 months:
None
The address(es) of the issuer's principal executive office:
258 South Military Trail
Deerfield Beach, FL. 33442
The address(es) of the issuer's principal place of business:
Check box if principal executive office and principal place of business are the same address: ☒
Has the issuer or any of its predecessors been in bankruptcy, receivership, or any similar proceeding in the past five years?
Yes: ☐ | No: ☒ |
If this issuer or any of its predecessors have been the subject of such proceedings, please provide additional details in the space below:
None
2) | Security Information | ||
Trading symbol: | TXTM | ||
Exact title and class of securities outstanding: | Common Stock | ||
CUSIP: | 74371E204 | ||
Par or stated value: | $0.00001 | ||
Total shares authorized: | 10,000,000,000as of date: September 30, 2021 | ||
Total shares outstanding: | 7,388,173,006as of date: September 30, 2021 | ||
Number of shares in the Public Float2: | 7,052,000,000 | as of date: September 30, 2021 | |
Total number of shareholders of record: | 77 | as of date: September 30, 2021 | |
All additional class(es) of publicly traded securities (if any): None | |||
Trading symbol: | N/A | ||
Exact title and class of securities outstanding: | N/A | ||
CUSIP: | N/A | ||
Par or stated value: | N/A |
2 "Public Float" shall mean the total number of unrestricted shares not held directly or indirectly by an officer, director, any person who is the beneficial owner of more than 10 percent of the total shares outstanding (a "control person"), or any affiliates thereof, or any immediate family members of officers, directors and control persons.
3
Total shares authorized: | N/A | as of date: N/A | ||
Total shares outstanding: | N/A | as of date: N/A | ||
Transfer Agent | ||||
Name: | Clear Trust, LLC | |||
Phone: | 813-235-4490 | |||
Email: | inbox@cleartrusttransfer.com | |||
Address: 16540 Pointe Village Dr. | ||||
Suite 205 | ||||
Lutz, Fl 33558 | ||||
Is the Transfer Agent registered under the Exchange Act?3 Yes: ☒ | No: ☐ |
- Issuance History
The goal of this section is to provide disclosure with respect to each event that resulted in any direct changes to the total shares outstanding of any class of the issuer's securities in the past two completed fiscal years and any subsequent interim period.
Disclosure under this item shall include, in chronological order, all offerings and issuances of securities, including debt convertible into equity securities, whether private or public, and all shares, or any other securities or options to acquire such securities, issued for services. Using the tabular format below, please describe these events.
A. Changes to the Number of Outstanding Shares
Check this box to indicate there were no changes to the number of outstanding shares within the past two completed fiscal years and any subsequent periods: ☐
[Table continues on Next Page]
3 To be included in the Pink Current Information tier, the transfer agent must be registered under the Exchange Act.
4
Shares Outstanding as of Second Most Recent | |||||||||
Fiscal Year End: | *Right-click the rows below and select "Insert" to add rows as needed. | ||||||||
Opening Balance | |||||||||
Date 12/31/2019 | Common: 4,574,316,008 | ||||||||
Preferred: 3,355,126 | |||||||||
Date of | Transaction | Number of | Class of | Value of | Were the | Individual/ Entity | Reason for | Restricted or | Exemption or |
Transaction | type (e.g. new | Shares | Securitie | shares | shares | Shares were | share issuance | Unrestricted | Registration |
issuance, | Issued (or | s | issued | issued at a | issued to | (e.g. for cash | as of this | Type. | |
cancellation, | cancelled) | ($/per | discount to | (entities must | or debt | filing. | |||
shares | share) at | market | have individual | conversion) | |||||
returned to | Issuance | price at the | with voting / | -OR- | |||||
treasury) | time of | investment | Nature of | ||||||
issuance? | control | Services | |||||||
(Yes/No) | disclosed). | Provided | |||||||
8/3/2020 | Issuance | 300,000,000 | Common | No | Bruce Lewis | Note conversion | Unrestricted | 4(a)1 | |
02/11/2021 | Issuance | 461,330,466 | Common | No | Union Capital, | Note conversion | Unrestricted | 4(a)1 | |
LLC | |||||||||
Yakov Borenstein | |||||||||
02/24/2021 | Issuance | 468,030,000 | Common | No | BB Winks LLC | Note conversion | Unrestricted | 4(a)1 | |
Craig Fisher | |||||||||
4/28/2021 | Issuance | 271,867,306 | Common | Yes | Union Capital, | Note conversion | Unrestricted | 4(a)1 | |
LLC | |||||||||
Yakov Borenstein | |||||||||
06/01/2021 | Issuance | 460,000,000 | Common | Yes | Bruce Lewis | Note Conversion | Unrestricted | 4(a)1 | |
6/22/21 | Issuance | 12,523,985 | Common | Yes | Gel Properties | Note Conversion | Unrestricted | 4(a)1 | |
LLC | |||||||||
6/23/21 | Issuance | 308,276,015 | Common | Yes | Gel Properties | Note Conversion | Unrestricted | 4(a)1 | |
LLC | |||||||||
6/22/21 | Issuance | 70,000,000 | Common | Yes | Gel Properties | Note Conversion | Unrestricted | 4(a)1 | |
LLC | |||||||||
6/22/21 | Issuance | 9,200,000 | Common | Yes | Gel Properties | Note Conversion | Unrestricted | 4(a)1 | |
LLC | |||||||||
9/23/21 | Issuance | 145,370,766 | Common | Yes | Lance Quartieri | Note Conversion | Unrestricted | 4(a)1 | |
9/20/21 | Issuance | 307,258,460 | Common | Yes | Richard Grossfeld | Pref A | Unrestricted | 4(a)1 | |
Conversion | |||||||||
9/20/21 | Cancellation | 22,151 | Pref A | N/A | Richard Grossfeld | Conversion to | N/A | N/A | |
common | |||||||||
Shares Outstanding on Date of This Report: | |||||||||
Ending Balance | |||||||||
Ending Balance: | |||||||||
Date 9/30/2021 | Common: 7,388,175,006 | ||||||||
Preferred: | 3,332.975 |
Example: A company with a fiscal year end of December 31st, in addressing this item for its quarter ended September 30, 2020, would include any events that resulted in changes to any class of its outstanding shares from the period beginning on January 1, 2018 through September 30, 2020 pursuant to the tabular format above.
Use the space below to provide any additional details, including footnotes to the table above:
B. Debt Securities, Including Promissory and Convertible Notes
5
Use the chart and additional space below to list and describe all outstanding promissory notes, convertible notes, convertible debentures, or any other debt instruments that may be converted into a class of the issuer's equity securities.
Check this box if there are no outstanding promissory, convertible notes or debt arrangements: ☐
Date of | Outstanding | Principal | Interest | Maturity | Conversion Terms (e.g. | Name of Noteholder | Reason for | ||
Note | Balance ($) | Amount | Accrued | Date | pricing mechanism for | (entities must have | Issuance (e.g. | ||
Issuance | at | ($) | determining conversion of | individual with voting | Loan, Services, | ||||
Issuance | instrument to shares) | / investment control | etc.) | ||||||
($) | disclosed). | ||||||||
12/30/11 | $39,052 | $77,000 | 12/30/12 | lesser of (60%) of the 5day | Bruce Lewis | Loan | |||
VWAP or last lowest | |||||||||
conversion price in the 120-day | |||||||||
period prior to date of | |||||||||
conversion (no conversion below | |||||||||
floor of .0001) | |||||||||
6/25/18 | $10,171 | $22,000 | 1,760 | 6/25/19 | Fixed price .0001 | BB Winks, LLC | Loan | ||
Craig Fischer | |||||||||
Use the space below to provide any additional details, including footnotes to the table above:
- Financial Statements
A. The following financial statements were prepared in accordance with:
☒ U.S. GAAP ☐ IFRS
- The financial statements for this reporting period were prepared by (name of individual)4:
Name: | John D. Patterson |
Title: | CPA |
Relationship to Issuer: | Accountant |
Provide the financial statements described below for the most recent fiscal year or quarter. For the initial disclosure statement (qualifying for Pink Current Information for the first time) please provide reports for the two previous fiscal years and any subsequent interim periods.
- Balance sheet;
- Statement of income;
- Statement of cash flows;
- Statement of Retained Earnings (Statement of Changes in Stockholders' Equity)
- Financial notes; and
- Audit letter, if audited
You may either (i) attach/append the financial statements to this disclosure statement or (ii) file the financial statements through OTCIQ as a separate report using the appropriate report name for the applicable period end. ("Annual Report," "Quarterly Report" or "Interim Report").
If you choose to publish the financial statements in a separate report as described above, you must state in the accompanying disclosure statement that such financial statements are incorporated by reference. You may reference the
4 The financial statements requested pursuant to this item must be prepared in accordance with US GAAP or IFRS by persons with sufficient financial skills.
6
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Protext Pharma Inc. published this content on 21 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 November 2021 21:33:11 UTC.